{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T19:25:48Z","timestamp":1793388348139,"version":"4.5.0"},"reference-count":200,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100007470","name":"Shaqra University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100007470","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmacology"],"published-print":{"date-parts":[[2025,9]]},"DOI":"10.1016\/j.ejphar.2025.177853","type":"journal-article","created":{"date-parts":[[2025,6,19]],"date-time":"2025-06-19T02:30:10Z","timestamp":1750300210000},"page":"177853","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":15,"special_numbering":"C","title":["Epigenetic reprogramming as a therapeutic strategy for neurodegenerative diseases: A complex and novel approach"],"prefix":"10.1016","volume":"1002","author":[{"ORCID":"https:\/\/orcid.org\/0009-0002-2000-2620","authenticated-orcid":false,"given":"Abdullah","family":"Alkhammash","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4780-7082","authenticated-orcid":false,"given":"Ghallab","family":"Alotaibi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejphar.2025.177853_bib1","doi-asserted-by":"crossref","first-page":"55","DOI":"10.2174\/1570159X13666151021111609","article-title":"Histone deacetylase (HDAC) Inhibitors-emerging roles in neuronal memory, learning, synaptic plasticity and neural regeneration","volume":"14","author":"Ahmad Ganai","year":"2016","journal-title":"Curr. Neuropharmacol."},{"key":"10.1016\/j.ejphar.2025.177853_bib2","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1186\/s12974-023-02745-6","article-title":"Microglia specific deletion of miR-155 in Alzheimer's disease mouse models reduces amyloid-\u03b2 pathology but causes hyperexcitability and seizures","volume":"20","author":"Aloi","year":"2023","journal-title":"J. Neuroinflammation"},{"key":"10.1016\/j.ejphar.2025.177853_bib3","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/j.cell.2016.09.006","article-title":"Inheritable silencing of endogenous genes by hit-and-run targeted epigenetic editing","volume":"167","author":"Amabile","year":"2016","journal-title":"Cell"},{"key":"10.1016\/j.ejphar.2025.177853_bib4","doi-asserted-by":"crossref","DOI":"10.3389\/fnagi.2021.709568","article-title":"The perspective of dysregulated lncRNAs in alzheimer's disease: a systematic scoping review","volume":"13","author":"Asadi","year":"2021","journal-title":"Front. Aging Neurosci."},{"key":"10.1016\/j.ejphar.2025.177853_bib5","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1007\/s40473-016-0083-4","article-title":"Epigenetic research in neuropsychiatric disorders: the \u201ctissue issue\u201d","volume":"3","author":"Bakulski","year":"2016","journal-title":"Curr. Behav. Neurosci. Rep."},{"key":"10.1016\/j.ejphar.2025.177853_bib6","doi-asserted-by":"crossref","first-page":"4654","DOI":"10.3390\/ijms22094654","article-title":"Histone methylation regulation in neurodegenerative disorders","volume":"22","author":"Basavarajappa","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ejphar.2025.177853_bib7","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1007\/978-3-319-53889-1_15","article-title":"Epigenetics of Huntington's disease","author":"Bassi","year":"2017","journal-title":"Neuroepigenomics in aging and disease"},{"key":"10.1016\/j.ejphar.2025.177853_bib8","doi-asserted-by":"crossref","first-page":"3306","DOI":"10.1080\/15548627.2021.1872189","article-title":"C9orf72 ALS-FTD: recent evidence for dysregulation of the autophagy-lysosome pathway at multiple levels","volume":"17","author":"Beckers","year":"2021","journal-title":"Autophagy"},{"key":"10.1016\/j.ejphar.2025.177853_bib9","unstructured":"Bekal, R.C., Pereira, S.D., Satyamoorthy, K., Neuroinflammation Mediated Epigenetic Reprogramming: Implications and Impact in Neurodegenerative Diseases."},{"key":"10.1016\/j.ejphar.2025.177853_bib10","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.brainres.2014.02.015","article-title":"Characterization of DNA hypermethylation in the cerebellum of c9FTD\/ALS patients","volume":"1584","author":"Belzil","year":"2014","journal-title":"Brain Res."},{"key":"10.1016\/j.ejphar.2025.177853_bib11","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.trsl.2018.10.002","article-title":"Epigenetics in amyotrophic lateral sclerosis: a role for histone post-translational modifications in neurodegenerative disease","volume":"204","author":"Bennett","year":"2019","journal-title":"Transl. Res."},{"key":"10.1016\/j.ejphar.2025.177853_bib12","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.2174\/1566524023666230907093451","article-title":"Neurodegenerative diseases: new hopes and perspectives","volume":"24","author":"Bhat","year":"2024","journal-title":"Curr. Mol. Med."},{"key":"10.1016\/j.ejphar.2025.177853_bib13","doi-asserted-by":"crossref","first-page":"79","DOI":"10.3389\/fnbeh.2015.00079","article-title":"The long-term impact of adverse caregiving environments on epigenetic modifications and telomeres","volume":"9","author":"Blaze","year":"2015","journal-title":"Front. Behav. Neurosci."},{"key":"10.1016\/j.ejphar.2025.177853_bib14","doi-asserted-by":"crossref","first-page":"3606","DOI":"10.3390\/cancers13143606","article-title":"Functional roles of bromodomain proteins in cancer","volume":"13","author":"Boyson","year":"2021","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.ejphar.2025.177853_bib15","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1007\/978-3-030-14792-1_5","article-title":"DNA methylation in neuronal development and disease","author":"Bruggeman","year":"2019","journal-title":"The DNA, RNA, and Histone Methylomes"},{"key":"10.1016\/j.ejphar.2025.177853_bib16","doi-asserted-by":"crossref","first-page":"1400","DOI":"10.1039\/C6TX00047A","article-title":"Epigenetic disruption and glucose homeostasis changes following low-dose maternal bisphenol A exposure","volume":"5","author":"Chang","year":"2016","journal-title":"Toxicol. Res."},{"key":"10.1016\/j.ejphar.2025.177853_bib17","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.1007\/s12640-021-00392-4","article-title":"SIRT1 protects dopaminergic neurons in parkinson's disease models via PGC-1\u03b1-mediated mitochondrial biogenesis","volume":"39","author":"Chen","year":"2021","journal-title":"Neurotox. Res."},{"key":"10.1016\/j.ejphar.2025.177853_bib18","doi-asserted-by":"crossref","DOI":"10.1111\/bpa.13012","article-title":"The epigenetic mechanisms involved in mitochondrial dysfunction: implication for Parkinson's disease","volume":"32","author":"Chen","year":"2022","journal-title":"Brain Pathol."},{"key":"10.1016\/j.ejphar.2025.177853_bib19","doi-asserted-by":"crossref","first-page":"1536","DOI":"10.1007\/s12035-024-04355-6","article-title":"SWI\/SNF complex connects signaling and epigenetic state in cells of nervous system","volume":"62","author":"Chmykhalo","year":"2025","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.ejphar.2025.177853_bib20","doi-asserted-by":"crossref","first-page":"2510","DOI":"10.3390\/ijms10062510","article-title":"Trends in the molecular pathogenesis and clinical therapeutics of common neurodegenerative disorders","volume":"10","author":"Choonara","year":"2009","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ejphar.2025.177853_bib21","doi-asserted-by":"crossref","first-page":"5636","DOI":"10.1038\/s41380-019-0610-2","article-title":"MicroRNA-298 reduces levels of human amyloid-\u03b2 precursor protein (APP), \u03b2-site APP-Converting enzyme 1 (BACE1) and specific tau protein moieties","volume":"26","author":"Chopra","year":"2021","journal-title":"Mol. Psychiatr."},{"key":"10.1016\/j.ejphar.2025.177853_bib22","doi-asserted-by":"crossref","first-page":"7513","DOI":"10.1007\/s12035-022-03042-8","article-title":"Proteinopathies: deciphering physiology and mechanisms to develop effective therapies for neurodegenerative diseases","volume":"59","author":"Chopra","year":"2022","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.ejphar.2025.177853_bib23","doi-asserted-by":"crossref","DOI":"10.3390\/ijms241310809","article-title":"Unraveling molecular and genetic insights into neurodegenerative diseases: advances in understanding Alzheimer's, Parkinson's, and Huntington's diseases and amyotrophic lateral sclerosis","volume":"24","author":"Ciurea","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ejphar.2025.177853_bib24","doi-asserted-by":"crossref","DOI":"10.3389\/fmolb.2021.659610","article-title":"A comprehensive analysis of the role of hnRNP A1 function and dysfunction in the pathogenesis of neurodegenerative disease","volume":"8","author":"Clarke","year":"2021","journal-title":"Front. Mol. Biosci."},{"key":"10.1016\/j.ejphar.2025.177853_bib25","doi-asserted-by":"crossref","first-page":"1334","DOI":"10.1016\/j.neurobiolaging.2013.11.031","article-title":"Global changes in DNA methylation and hydroxymethylation in alzheimer's disease human brain","volume":"35","author":"Coppieters","year":"2014","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.ejphar.2025.177853_bib26","first-page":"4207","article-title":"Downregulated glia interplay and increased miRNA-155 as promising markers to track ALS at an early stage","volume":"55","author":"Cunha","year":"2018","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.ejphar.2025.177853_bib27","doi-asserted-by":"crossref","first-page":"7207","DOI":"10.3390\/molecules27217207","article-title":"Potential of therapeutic small molecules in apoptosis regulation in the treatment of neurodegenerative diseases: an updated review","volume":"27","author":"Dailah","year":"2022","journal-title":"Molecules"},{"key":"10.1016\/j.ejphar.2025.177853_bib28","doi-asserted-by":"crossref","first-page":"17","DOI":"10.52214\/cusj.v17i1.10288","article-title":"Molecular mechanisms and clinical features of huntington disease: a fatal neurodegenerative disorder with autosomal dominant inheritance","volume":"17","author":"Datta","year":"2023","journal-title":"Columbia Undergrad. Sci. J."},{"key":"10.1016\/j.ejphar.2025.177853_bib29","doi-asserted-by":"crossref","first-page":"719","DOI":"10.3390\/cells13080719","article-title":"Epigenetic changes in Alzheimer's disease: DNA methylation and histone modification","volume":"13","author":"De Plano","year":"2024","journal-title":"Cells"},{"key":"10.1016\/j.ejphar.2025.177853_bib30","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1002\/jcp.21678","article-title":"Epigenetic control","volume":"219","author":"Delcuve","year":"2009","journal-title":"J. Cell. Physiol."},{"key":"10.1016\/j.ejphar.2025.177853_bib31","doi-asserted-by":"crossref","first-page":"159","DOI":"10.3892\/etm.2020.9288","article-title":"miR-132 improves the cognitive function of rats with alzheimer's disease by inhibiting the MAPK1 signal pathway","volume":"20","author":"Deng","year":"2020","journal-title":"Exp. Ther. Med."},{"key":"10.1016\/j.ejphar.2025.177853_bib32","doi-asserted-by":"crossref","first-page":"4031","DOI":"10.1002\/jcp.29299","article-title":"Polycomb repressive complex 1: regulators of neurogenesis from embryonic to adult stage","volume":"235","author":"Desai","year":"2020","journal-title":"J. Cell. Physiol."},{"key":"10.1016\/j.ejphar.2025.177853_bib33","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.molcel.2014.08.028","article-title":"mRNA destabilization is the dominant effect of Mammalian microRNAs by the time substantial repression ensues","volume":"56","author":"Eichhorn","year":"2014","journal-title":"Mol. Cell"},{"key":"10.1016\/j.ejphar.2025.177853_bib34","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1104\/pp.113.234211","article-title":"Epigenetics: beyond chromatin modifications and complex genetic regulation","volume":"165","author":"Eichten","year":"2014","journal-title":"Plant Physiol."},{"key":"10.1016\/j.ejphar.2025.177853_bib35","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1007\/s00401-018-1880-5","article-title":"MicroRNA-132 provides neuroprotection for tauopathies via multiple signaling pathways","volume":"136","author":"El Fatimy","year":"2018","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.ejphar.2025.177853_bib36","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.expneurol.2015.12.022","article-title":"C9orf72 promoter hypermethylation is reduced while hydroxymethylation is acquired during reprogramming of ALS patient cells","volume":"277","author":"Esanov","year":"2016","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.ejphar.2025.177853_bib37","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s10571-025-01538-0","article-title":"LncRNAs orchestrating neuroinflammation: a comprehensive review","volume":"45","author":"Esmaeili","year":"2025","journal-title":"Cell. Mol. Neurobiol."},{"key":"10.1016\/j.ejphar.2025.177853_bib38","doi-asserted-by":"crossref","first-page":"2008","DOI":"10.1016\/j.bbadis.2018.11.014","article-title":"Acetylation as a major determinant to microtubule-dependent autophagy: relevance to Alzheimer's and parkinson disease pathology","volume":"1865","author":"Esteves","year":"2019","journal-title":"Biochim. Biophys. Acta (BBA) - Mol. Basis Dis."},{"key":"10.1016\/j.ejphar.2025.177853_bib39","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1038\/nn.2514","article-title":"Dnmt1 and Dnmt3a maintain DNA methylation and regulate synaptic function in adult forebrain neurons","volume":"13","author":"Feng","year":"2010","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.ejphar.2025.177853_bib40","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.jns.2014.12.017","article-title":"Epigenetic mechanisms in parkinson's disease","volume":"349","author":"Feng","year":"2015","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.ejphar.2025.177853_bib41","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13148-019-0701-6","article-title":"Whole-genome DNA hyper-methylation in iPSC-derived dopaminergic neurons from Parkinson's disease patients","volume":"11","author":"Fern\u00e1ndez-Santiago","year":"2019","journal-title":"Clin. Epigenet."},{"key":"10.1016\/j.ejphar.2025.177853_bib42","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.bcp.2015.12.005","article-title":"Bromodomains: structure, function and pharmacology of inhibition","volume":"106","author":"Ferri","year":"2016","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.ejphar.2025.177853_bib43","doi-asserted-by":"crossref","first-page":"5105","DOI":"10.2174\/1381612811319280009","article-title":"Potential roles of HDAC inhibitors in mitigating ischemia-induced brain damage and facilitating endogenous regeneration and recovery","volume":"19","author":"Fessler","year":"2013","journal-title":"Curr. Pharm. Des."},{"key":"10.1016\/j.ejphar.2025.177853_bib44","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1038\/nrd4286","article-title":"Targeting bromodomains: epigenetic readers of lysine acetylation","volume":"13","author":"Filippakopoulos","year":"2014","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.ejphar.2025.177853_bib45","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2023.1305933","article-title":"Immunological dimensions of neuroinflammation and microglial activation: exploring innovative immunomodulatory approaches to mitigate neuroinflammatory progression","volume":"14","author":"Fornari Laurindo","year":"2024","journal-title":"Front. Immunol."},{"key":"10.1016\/j.ejphar.2025.177853_bib46","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1093\/bfgp\/ell032","article-title":"Simple histone acetylation plays a complex role in the regulation of gene expression","volume":"5","author":"Fukuda","year":"2006","journal-title":"Briefings Funct. Genomics"},{"key":"10.1016\/j.ejphar.2025.177853_bib47","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1002\/ddr.21515","article-title":"Structure\u2013activity study of fluorine or chlorine\u2010substituted cinnamic acid derivatives with tertiary amine side chain in acetylcholinesterase and butyrylcholinesterase inhibition","volume":"80","author":"Gao","year":"2019","journal-title":"Drug Dev. Res."},{"key":"10.1016\/j.ejphar.2025.177853_bib48","doi-asserted-by":"crossref","unstructured":"Ghosh, A., Pal, A., Sagar, R., Gaharwar, U., Singh, H., Kumar, D., Recent Therapeutic Approaches for Neurodegenerative Disorders, Synaptic Plasticity in Neurodegenerative Disorders. CRC Press, pp. 115-156.","DOI":"10.1201\/9781003464648-8"},{"key":"10.1016\/j.ejphar.2025.177853_bib49","doi-asserted-by":"crossref","DOI":"10.3390\/ijms232315218","article-title":"The role of epigenetics in neuroinflammatory-driven diseases","volume":"23","author":"Giallongo","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ejphar.2025.177853_bib50","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1038\/hdy.2010.54","article-title":"Epigenetics and gene expression","volume":"105","author":"Gibney","year":"2010","journal-title":"Heredity"},{"key":"10.1016\/j.ejphar.2025.177853_bib51","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3233\/JHD-140134","article-title":"Epigenetic mechanisms involved in huntington's disease pathogenesis","volume":"4","author":"Glajch","year":"2015","journal-title":"J. Huntingt. Dis."},{"key":"10.1016\/j.ejphar.2025.177853_bib52","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1038\/nature10849","article-title":"An epigenetic blockade of cognitive functions in the neurodegenerating brain","volume":"483","author":"Gr\u00e4ff","year":"2012","journal-title":"Nature"},{"key":"10.1016\/j.ejphar.2025.177853_bib53","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2022.113248","article-title":"Dioscin alleviates alzheimer's disease through regulating RAGE\/NOX4 mediated oxidative stress and inflammation","volume":"152","author":"Guan","year":"2022","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.ejphar.2025.177853_bib54","doi-asserted-by":"crossref","DOI":"10.15252\/emmm.202012188","article-title":"Targeted attenuation of elevated histone marks at SNCA alleviates \u03b1\u2010synuclein in parkinson's disease","volume":"13","author":"Guhathakurta","year":"2021","journal-title":"EMBO Mol. Med."},{"key":"10.1016\/j.ejphar.2025.177853_bib55","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1517\/13543784.17.2.169","article-title":"Histone deacetylase inhibitors: possible implications for neurodegenerative disorders","volume":"17","author":"Hahnen","year":"2008","journal-title":"Expet Opin. Invest. Drugs"},{"key":"10.1016\/j.ejphar.2025.177853_bib56","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1016\/j.biopsych.2020.02.001","article-title":"The \u03b2-secretase BACE1 in Alzheimer's disease","volume":"89","author":"Hampel","year":"2021","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.ejphar.2025.177853_bib57","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.pharmthera.2013.05.010","article-title":"Epigenetic targeting of histone deacetylase: therapeutic potential in parkinson's disease?","volume":"140","author":"Harrison","year":"2013","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.ejphar.2025.177853_bib58","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2021.774751","article-title":"Methylation and expression of mutant FUS in motor neurons differentiated from induced pluripotent stem cells from ALS patients","volume":"9","author":"Hartung","year":"2021","journal-title":"Front. Cell Dev. Biol."},{"key":"10.1016\/j.ejphar.2025.177853_bib59","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1038\/nbt.3199","article-title":"Epigenome editing by a CRISPR-Cas9-based acetyltransferase activates genes from promoters and enhancers","volume":"33","author":"Hilton","year":"2015","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.ejphar.2025.177853_bib60","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1089\/scd.2018.0258","article-title":"Inhibition of Ezh2 in vitro and the decline of Ezh2 in developing midbrain promote dopaminergic neurons differentiation through modifying H3K27me3","volume":"28","author":"Hong","year":"2019","journal-title":"Stem Cell. Dev."},{"key":"10.1016\/j.ejphar.2025.177853_bib61","article-title":"Genome-wide study of DNA methylation in amyotrophic lateral sclerosis identifies differentially methylated loci and implicates metabolic, inflammatory and cholesterol pathways","author":"Hop","year":"2021","journal-title":"medRxiv"},{"key":"10.1016\/j.ejphar.2025.177853_bib62","first-page":"1130","article-title":"Increased epigenetic age and granulocyte counts in the blood of parkinson's disease patients","volume":"7","author":"Horvath","year":"2015","journal-title":"Aging (Albany N. Y.)"},{"key":"10.1016\/j.ejphar.2025.177853_bib63","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1038\/nrg2936","article-title":"Gene silencing by microRNAs: contributions of translational repression and mRNA decay","volume":"12","author":"Huntzinger","year":"2011","journal-title":"Nat. Rev. Genet."},{"key":"10.1016\/j.ejphar.2025.177853_bib64","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1038\/nrn.2017.46","article-title":"The emerging field of epigenetics in neurodegeneration and neuroprotection","volume":"18","author":"Hwang","year":"2017","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.ejphar.2025.177853_bib65","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.3390\/cells13121063","article-title":"Non-coding RNAs in neurological and neuropsychiatric disorders: unraveling the hidden players in disease pathogenesis","volume":"13","author":"Ilieva","year":"2024","journal-title":"Cells"},{"key":"10.1016\/j.ejphar.2025.177853_bib66","first-page":"4117","article-title":"Mechanism suppressing H3K9 trimethylation in pluripotent stem cells and its demise by polyQ-expanded huntingtin mutations","volume":"27","author":"Irmak","year":"2018","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.ejphar.2025.177853_bib67","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1038\/nm.2558","article-title":"Neuroprotective role of Sirt1 in Mammalian models of huntington's disease through activation of multiple Sirt1 targets","volume":"18","author":"Jiang","year":"2012","journal-title":"Nat. Med."},{"key":"10.1016\/j.ejphar.2025.177853_bib68","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1186\/s13578-023-00953-4","article-title":"Small molecule modulators of chromatin remodeling: from neurodevelopment to neurodegeneration","volume":"13","author":"Jiang","year":"2023","journal-title":"Cell Biosci."},{"key":"10.1016\/j.ejphar.2025.177853_bib69","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1007\/978-3-319-53889-1_14","article-title":"Epigenetic mechanisms of gene regulation in amyotrophic lateral sclerosis","author":"Jimenez-Pacheco","year":"2017","journal-title":"Neuroepigenomics Aging Dis."},{"key":"10.1016\/j.ejphar.2025.177853_bib70","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12974-015-0260-5","article-title":"RNA sequencing reveals distinct mechanisms underlying BET inhibitor JQ1-mediated modulation of the LPS-Induced activation of BV-2 microglial cells","volume":"12","author":"Jung","year":"2015","journal-title":"J. Neuroinflammation"},{"key":"10.1016\/j.ejphar.2025.177853_bib71","doi-asserted-by":"crossref","first-page":"766","DOI":"10.3390\/biology10080766","article-title":"Epigenetics for crop improvement in times of global change","volume":"10","author":"Kakoulidou","year":"2021","journal-title":"Biology"},{"key":"10.1016\/j.ejphar.2025.177853_bib72","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1016\/j.neuropharm.2013.04.002","article-title":"Role of BDNF epigenetics in activity-dependent neuronal plasticity","volume":"76","author":"Karpova","year":"2014","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.ejphar.2025.177853_bib73","doi-asserted-by":"crossref","first-page":"90","DOI":"10.3390\/biology11010090","article-title":"DNA methylation: a promising approach in management of Alzheimer's disease and other neurodegenerative disorders","volume":"11","author":"Kaur","year":"2022","journal-title":"Biology"},{"key":"10.1016\/j.ejphar.2025.177853_bib74","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1038\/npp.2009.197","article-title":"Inhibitors of class 1 histone deacetylases reverse contextual memory deficits in a mouse model of alzheimer's disease","volume":"35","author":"Kilgore","year":"2010","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.ejphar.2025.177853_bib75","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1038\/s41531-022-00355-2","article-title":"Parkinson's disease-associated, sex-specific changes in DNA methylation at PARK7 (DJ-1), SLC17A6 (VGLUT2), PTPRN2 (IA-2\u03b2), and NR4A2 (NURR1) in cortical neurons","volume":"8","author":"Kochmanski","year":"2022","journal-title":"npj Parkinson's Dis."},{"key":"10.1016\/j.ejphar.2025.177853_bib76","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.neuint.2017.07.007","article-title":"Application of the gene editing tool, CRISPR-Cas9, for treating neurodegenerative diseases","volume":"112","author":"Kolli","year":"2018","journal-title":"Neurochem. Int."},{"key":"10.1016\/j.ejphar.2025.177853_bib77","doi-asserted-by":"crossref","first-page":"352","DOI":"10.3390\/futurepharmacol4020020","article-title":"Nanotechnology-driven therapeutic innovations in neurodegenerative disorders: a focus on Alzheimer's and Parkinson's disease","volume":"4","author":"Krsek","year":"2024","journal-title":"Future Pharmacol."},{"key":"10.1016\/j.ejphar.2025.177853_bib78","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1007\/s00401-016-1590-9","article-title":"Epigenetic regulation in Parkinson's disease","volume":"132","author":"Labb\u00e9","year":"2016","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.ejphar.2025.177853_bib79","first-page":"58","article-title":"Epigenetic mechanisms in neurological and neurodegenerative diseases","volume":"9","author":"Landgrave-G\u00f3mez","year":"2015","journal-title":"Front. Cell. Neurosci."},{"key":"10.1016\/j.ejphar.2025.177853_bib80","doi-asserted-by":"crossref","first-page":"2698","DOI":"10.3390\/ijms18122698","article-title":"microRNAs in Parkinson's disease: from pathogenesis to novel diagnostic and therapeutic approaches","volume":"18","author":"Leggio","year":"2017","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ejphar.2025.177853_bib81","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1016\/j.bbagen.2008.12.006","article-title":"Histone modification patterns and epigenetic codes","volume":"1790","author":"Lennartsson","year":"2009","journal-title":"Biochimica et biophysica acta (BBA)-general subjects"},{"key":"10.1016\/j.ejphar.2025.177853_bib82","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1016\/j.chemosphere.2019.05.064","article-title":"Identification of miRNA-7 as a regulator of brain-derived neurotrophic factor\/\u03b1-synuclein axis in atrazine-induced Parkinson's disease by peripheral blood and brain microRNA profiling","volume":"233","author":"Li","year":"2019","journal-title":"Chemosphere"},{"key":"10.1016\/j.ejphar.2025.177853_bib83","article-title":"SIRT1 deacetylates TET2 and promotes its ubiquitination degradation to achieve neuroprotection against parkinson's disease","volume":"12","author":"Li","year":"2021","journal-title":"Front. Neurol."},{"key":"10.1016\/j.ejphar.2025.177853_bib84","doi-asserted-by":"crossref","first-page":"1848","DOI":"10.1111\/cns.14143","article-title":"MicroRNA\u2010128 suppresses tau phosphorylation and reduces amyloid\u2010beta accumulation by inhibiting the expression of GSK3\u03b2, APPBP2, and mTOR in alzheimer's disease","volume":"29","author":"Li","year":"2023","journal-title":"CNS Neurosci. Ther."},{"key":"10.1016\/j.ejphar.2025.177853_bib85","article-title":"The epigenetic modification of DNA methylation in neurological diseases","volume":"15","author":"Li","year":"2024","journal-title":"Front. Immunol."},{"key":"10.1016\/j.ejphar.2025.177853_bib86","doi-asserted-by":"crossref","first-page":"2250","DOI":"10.7150\/thno.107436","article-title":"Epigenetic regulation-mediated disorders in dopamine transporter endocytosis: a novel mechanism for the pathogenesis of parkinson's disease","volume":"15","author":"Liang","year":"2025","journal-title":"Theranostics"},{"key":"10.1016\/j.ejphar.2025.177853_bib87","doi-asserted-by":"crossref","first-page":"47","DOI":"10.34133\/cbsystems.0047","article-title":"Emulation of brain metabolic activities based on a dynamically controllable optical phantom","volume":"4","author":"Lin","year":"2023","journal-title":"Cyborg and Bionic Systems"},{"key":"10.1016\/j.ejphar.2025.177853_bib88","article-title":"MicroRNA-132 promotes neurons cell apoptosis and activates tau phosphorylation by targeting GTDC-1 in alzheimer's disease","volume":"23","author":"Liu","year":"2019","journal-title":"Eur. Rev. Med. Pharmacol. Sci."},{"key":"10.1016\/j.ejphar.2025.177853_bib89","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/j.cell.2016.08.056","article-title":"Editing DNA methylation in the Mammalian genome","volume":"167","author":"Liu","year":"2016","journal-title":"Cell"},{"key":"10.1016\/j.ejphar.2025.177853_bib90","doi-asserted-by":"crossref","first-page":"837","DOI":"10.14336\/AD.2021.1119","article-title":"LncRNAs as the regulators of brain function and therapeutic targets for Alzheimer's disease","volume":"13","author":"Liu","year":"2022","journal-title":"Aging Dis."},{"key":"10.1016\/j.ejphar.2025.177853_bib91","doi-asserted-by":"crossref","first-page":"4282","DOI":"10.3390\/ijms21124282","article-title":"How do post-translational modifications influence the pathomechanistic landscape of Huntington's disease? A comprehensive review","volume":"21","author":"Lontay","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ejphar.2025.177853_bib92","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/j.arr.2017.09.002","article-title":"Cell reprogramming: therapeutic potential and the promise of rejuvenation for the aging brain","volume":"40","author":"L\u00f3pez-Le\u00f3n","year":"2017","journal-title":"Ageing Res. Rev."},{"key":"10.1016\/j.ejphar.2025.177853_bib93","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1002\/ddr.21726","article-title":"Nitrogen\u2010containing flavonoid and their analogs with diverse b\u2010ring in acetylcholinesterase and butyrylcholinesterase inhibition","volume":"81","author":"Lu","year":"2020","journal-title":"Drug Dev. Res."},{"key":"10.1016\/j.ejphar.2025.177853_bib94","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1038\/s41586-020-2975-4","article-title":"Reprogramming to recover youthful epigenetic information and restore vision","volume":"588","author":"Lu","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.ejphar.2025.177853_bib95","doi-asserted-by":"crossref","first-page":"3223","DOI":"10.1038\/s41598-025-85444-x","article-title":"Comprehensive pan-cancer analysis reveals NTN1 as an immune infiltrate risk factor and its potential prognostic value in SKCM","volume":"15","author":"Luan","year":"2025","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ejphar.2025.177853_bib96","doi-asserted-by":"crossref","first-page":"5051","DOI":"10.2174\/13816128113199990382","article-title":"Lysine acetyltransferases CBP and p300 as therapeutic targets in cognitive and neurodegenerative disorders","volume":"19","author":"M Valor","year":"2013","journal-title":"Curr. Pharm. Des."},{"key":"10.1016\/j.ejphar.2025.177853_bib97","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1111\/nan.12518","article-title":"HDAC 2 dysregulation in the nucleus basalis of meynert during the progression of alzheimer's disease","volume":"45","author":"Mahady","year":"2019","journal-title":"Neuropathol. Appl. Neurobiol."},{"key":"10.1016\/j.ejphar.2025.177853_bib98","doi-asserted-by":"crossref","DOI":"10.3390\/ijms222212280","article-title":"Epigenetic mechanisms in memory and cognitive decline associated with aging and Alzheimer's disease","volume":"22","author":"Maity","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ejphar.2025.177853_bib99","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1007\/s13238-015-0168-y","article-title":"Secreted miR-34a in astrocytic shedding vesicles enhanced the vulnerability of dopaminergic neurons to neurotoxins by targeting Bcl-2","volume":"6","author":"Mao","year":"2015","journal-title":"Protein Cell"},{"key":"10.1016\/j.ejphar.2025.177853_bib100","first-page":"3","article-title":"Mechanisms for neuronal degeneration in amyotrophic lateral sclerosis and in models of motor neuron death","volume":"5","author":"Martin","year":"2000","journal-title":"Int. J. Mol. Med."},{"key":"10.1016\/j.ejphar.2025.177853_bib101","series-title":"Baylor University Medical Center Proceedings","first-page":"103","article-title":"Improving quality and reducing inequities: a challenge in achieving best care","author":"Mayberry","year":"2006"},{"key":"10.1016\/j.ejphar.2025.177853_bib102","first-page":"429","article-title":"Investigating the relationship between DNA methylation age acceleration and risk factors for alzheimer's disease","volume":"10","author":"McCartney","year":"2018","journal-title":"Alzheimer's Dement.: Diagnosis, Assessment & Disease Monitoring"},{"key":"10.1016\/j.ejphar.2025.177853_bib103","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1089\/rej.2019.2271","article-title":"Epigenetic age reversal by cell-extrinsic and cell-intrinsic means","volume":"22","author":"Mendelsohn","year":"2019","journal-title":"Rejuvenation Res."},{"key":"10.1016\/j.ejphar.2025.177853_bib104","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1016\/j.nlm.2007.07.016","article-title":"DNA methylation and histone acetylation work in concert to regulate memory formation and synaptic plasticity","volume":"89","author":"Miller","year":"2008","journal-title":"Neurobiol. Learn. Mem."},{"key":"10.1016\/j.ejphar.2025.177853_bib105","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1128\/MCB.00589-15","article-title":"Regulation of neuronal cell cycle and apoptosis by microRNA 34a","volume":"36","author":"Modi","year":"2016","journal-title":"Mol. Cell Biol."},{"key":"10.1016\/j.ejphar.2025.177853_bib106","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1177\/0271678X20912965","article-title":"TET3 regulates DNA hydroxymethylation of neuroprotective genes following focal ischemia","volume":"41","author":"Morris-Blanco","year":"2021","journal-title":"J. Cerebr. Blood Flow Metabol."},{"key":"10.1016\/j.ejphar.2025.177853_bib107","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1016\/j.molonc.2012.09.005","article-title":"Chromatin remodeling in cancer: a gateway to regulate gene transcription","volume":"6","author":"Nair","year":"2012","journal-title":"Mol. Oncol."},{"key":"10.1016\/j.ejphar.2025.177853_bib108","doi-asserted-by":"crossref","first-page":"2354","DOI":"10.1073\/pnas.1221292110","article-title":"Extensive changes in DNA methylation are associated with expression of mutant huntingtin","volume":"110","author":"Ng","year":"2013","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.ejphar.2025.177853_bib109","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1007\/s13237-021-00369-w","article-title":"ATP-Dependent chromatin remodelers and aging","volume":"64","author":"Ngubo","year":"2021","journal-title":"Nucleus (Karachi)"},{"key":"10.1016\/j.ejphar.2025.177853_bib110","doi-asserted-by":"crossref","first-page":"1","DOI":"10.4172\/2161-0460.1000159","article-title":"Hyperphosphorylation of tau protein in Down's dementia and Alzheimer's disease: methylation and implications in prevention and therapy","volume":"4","author":"Nichols","year":"2014","journal-title":"J. Alzheimers Dis. Parkinsonism"},{"key":"10.1016\/j.ejphar.2025.177853_bib111","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1007\/s11011-021-00800-w","article-title":"Neurodegenerative disorders of alzheimer, parkinsonism, amyotrophic lateral sclerosis and multiple sclerosis: an early diagnostic approach for precision treatment","volume":"37","author":"Nishit","year":"2022","journal-title":"Metab. Brain Dis."},{"key":"10.1016\/j.ejphar.2025.177853_bib112","doi-asserted-by":"crossref","first-page":"1719","DOI":"10.1016\/j.cell.2016.11.052","article-title":"In vivo amelioration of age-associated hallmarks by partial reprogramming","volume":"167","author":"Ocampo","year":"2016","journal-title":"Cell"},{"key":"10.1016\/j.ejphar.2025.177853_bib113","doi-asserted-by":"crossref","DOI":"10.3390\/ijms241512498","article-title":"Roles of non-coding RNA in Alzheimer's disease pathophysiology","volume":"24","author":"Olufunmilayo","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ejphar.2025.177853_bib114","series-title":"Comprehensive Analysis of DNA Methylation Regulator DNA Methyltransferase (DNMT) Family and ten-eleven-translocation (TET) Enzymes Family in Pan-Cancer","author":"Ouyang","year":"2021"},{"key":"10.1016\/j.ejphar.2025.177853_bib115","doi-asserted-by":"crossref","first-page":"3239","DOI":"10.1093\/nar\/gkac123","article-title":"Determinants of heritable gene silencing for KRAB-dCas9+ DNMT3 and Ezh2-dCas9+ DNMT3 hit-and-run epigenome editing","volume":"50","author":"O'Geen","year":"2022","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.ejphar.2025.177853_bib116","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1038\/s41392-022-01078-9","article-title":"The role of histone modifications: from neurodevelopment to neurodiseases","volume":"7","author":"Park","year":"2022","journal-title":"Signal Transduct. Targeted Ther."},{"key":"10.1016\/j.ejphar.2025.177853_bib117","first-page":"1","article-title":"Neurodegenerative disorders of alzheimer, parkinsonism, amyotrophic lateral sclerosis and multiple sclerosis: an early diagnostic approach for precision treatment","author":"Pathak","year":"2021","journal-title":"Metab. Brain Dis."},{"key":"10.1016\/j.ejphar.2025.177853_bib118","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1093\/bfgp\/elz035","article-title":"Epigenome editing by CRISPR\/Cas9 in clinical settings: possibilities and challenges","volume":"19","author":"Pei","year":"2020","journal-title":"Briefings Funct. Genomics"},{"key":"10.1016\/j.ejphar.2025.177853_bib119","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1111\/ane.12545","article-title":"Current status of treating neurodegenerative disease with induced pluripotent stem cells","volume":"135","author":"Pen","year":"2017","journal-title":"Acta Neurol. Scand."},{"key":"10.1016\/j.ejphar.2025.177853_bib120","doi-asserted-by":"crossref","first-page":"647","DOI":"10.3390\/antiox9080647","article-title":"Mitochondrial dysfunction, oxidative stress, and neuroinflammation: intertwined roads to neurodegeneration","volume":"9","author":"Picca","year":"2020","journal-title":"Antioxidants"},{"key":"10.1016\/j.ejphar.2025.177853_bib121","doi-asserted-by":"crossref","first-page":"2783","DOI":"10.2174\/0929867327666200705225821","article-title":"Transcriptional dysregulation in Huntington's disease: the role in pathogenesis and potency for pharmacological targeting","volume":"28","author":"Pogoda","year":"2021","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/j.ejphar.2025.177853_bib122","doi-asserted-by":"crossref","first-page":"606","DOI":"10.3390\/antiox13050606","article-title":"Role of epigenetic modulation in neurodegenerative diseases: implications of phytochemical interventions","volume":"13","author":"Prasanth","year":"2024","journal-title":"Antioxidants"},{"key":"10.1016\/j.ejphar.2025.177853_bib123","doi-asserted-by":"crossref","first-page":"9936","DOI":"10.3390\/ijms25189936","article-title":"Insights into the role of microRNAs as clinical tools for diagnosis, prognosis, and as therapeutic targets in alzheimer's disease","volume":"25","author":"Puranik","year":"2024","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ejphar.2025.177853_bib124","doi-asserted-by":"crossref","first-page":"175","DOI":"10.3389\/fncel.2017.00175","article-title":"Regulatory roles of long non-coding RNAs in the central nervous system and associated neurodegenerative diseases","volume":"11","author":"Quan","year":"2017","journal-title":"Front. Cell. Neurosci."},{"key":"10.1016\/j.ejphar.2025.177853_bib125","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1016\/j.molmed.2013.09.003","article-title":"Developing epigenetic diagnostics and therapeutics for brain disorders","volume":"19","author":"Qureshi","year":"2013","journal-title":"Trends Mol. Med."},{"key":"10.1016\/j.ejphar.2025.177853_bib126","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1016\/j.bcp.2004.05.042","article-title":"Redox modulation of chromatin remodeling: impact on histone acetylation and deacetylation, NF-\u03baB and pro-inflammatory gene expression","volume":"68","author":"Rahman","year":"2004","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.ejphar.2025.177853_bib127","doi-asserted-by":"crossref","first-page":"1618","DOI":"10.1007\/s11064-021-03334-w","article-title":"Epigenetic modulation in Parkinson's disease and potential treatment therapies","volume":"46","author":"Rathore","year":"2021","journal-title":"Neurochem. Res."},{"key":"10.1016\/j.ejphar.2025.177853_bib128","doi-asserted-by":"crossref","first-page":"1156","DOI":"10.1016\/j.bbrc.2016.08.067","article-title":"A critical evaluation of neuroprotective and neurodegenerative MicroRNAs in alzheimer's disease","volume":"483","author":"Reddy","year":"2017","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.ejphar.2025.177853_bib129","first-page":"327","article-title":"Neurodegenerative disorders treatment: the MicroRNA role","volume":"17","author":"Ridolfi","year":"2017","journal-title":"Curr. Gene Ther."},{"key":"10.1016\/j.ejphar.2025.177853_bib130","doi-asserted-by":"crossref","first-page":"3958","DOI":"10.2174\/138161209789649303","article-title":"Turning REST\/NRSF dysfunction in huntington's disease into a pharmaceutical target","volume":"15","author":"Rigamonti","year":"2009","journal-title":"Curr. Pharm. Des."},{"key":"10.1016\/j.ejphar.2025.177853_bib131","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1038\/nature17172","article-title":"Memory retrieval by activating engram cells in mouse models of early Alzheimer's disease","volume":"531","author":"Roy","year":"2016","journal-title":"Nature"},{"key":"10.1016\/j.ejphar.2025.177853_bib132","doi-asserted-by":"crossref","DOI":"10.3389\/fgene.2021.784996","article-title":"Deregulation of ncRNA in neurodegenerative disease: focus on circRNA, lncRNA and miRNA in amyotrophic lateral sclerosis","volume":"12","author":"Ruffo","year":"2021","journal-title":"Front. Genet."},{"key":"10.1016\/j.ejphar.2025.177853_bib133","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1038\/ncpneuro0199","article-title":"Mechanisms of disease: histone modifications in huntington's disease","volume":"2","author":"Sadri-Vakili","year":"2006","journal-title":"Nat. Clin. Pract. Neurol."},{"key":"10.1016\/j.ejphar.2025.177853_bib134","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1586\/14737175.2015.1114886","article-title":"MicroRNA machinery in Parkinson's disease: a platform for neurodegenerative diseases","volume":"22","author":"Saghazadeh","year":"2022","journal-title":"Expert Rev. Neurother."},{"key":"10.1016\/j.ejphar.2025.177853_bib135","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.00088-19","article-title":"Histone deacetylase inhibitor suberoylanilide hydroxamic acid suppresses human adenovirus gene expression and replication","volume":"93","author":"Saha","year":"2019","journal-title":"J. Virol."},{"key":"10.1016\/j.ejphar.2025.177853_bib136","doi-asserted-by":"crossref","DOI":"10.3389\/fgene.2020.00171","article-title":"DNA methylation biomarkers in aging and age-related diseases","volume":"11","author":"Salameh","year":"2020","journal-title":"Front. Genet."},{"key":"10.1016\/j.ejphar.2025.177853_bib137","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1096\/fj.201601308","article-title":"microRNA\u2010132: a key noncoding RNA operating in the cellular phase of alzheimer's disease","volume":"31","author":"Salta","year":"2017","journal-title":"FASEB J."},{"key":"10.1016\/j.ejphar.2025.177853_bib138","doi-asserted-by":"crossref","DOI":"10.1038\/tp.2015.214","article-title":"Human DNA methylomes of neurodegenerative diseases show common epigenomic patterns","volume":"6","author":"Sanchez-Mut","year":"2016","journal-title":"Transl. Psychiatry"},{"key":"10.1016\/j.ejphar.2025.177853_bib139","doi-asserted-by":"crossref","first-page":"7830","DOI":"10.1007\/s12035-024-03974-3","article-title":"The alpha-synuclein gene (SNCA) is a genomic target of Methyl-CpG binding protein 2 (MeCP2)\u2014Implications for parkinson's disease and Rett syndrome","volume":"61","author":"Schmitt","year":"2024","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.ejphar.2025.177853_bib140","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1016\/j.bbagrm.2010.08.012","article-title":"Tuning acetylation levels with HAT activators: therapeutic strategy in neurodegenerative diseases","volume":"1799","author":"Selvi","year":"2010","journal-title":"Biochimica et Biophysica Acta (BBA)-Gene Regul. Mech."},{"key":"10.1016\/j.ejphar.2025.177853_bib141","doi-asserted-by":"crossref","first-page":"60","DOI":"10.32607\/actanaturae.10925","article-title":"Promising molecular targets for pharmacological therapy of neurodegenerative pathologies","volume":"12","author":"Sergey","year":"2020","journal-title":"Acta Naturae (\u0430\u043d\u0433\u043b\u043e\u044f\u0437\u044b\u0447\u043d\u0430\u044f \u0432\u0435\u0440\u0441\u0438\u044f)"},{"key":"10.1016\/j.ejphar.2025.177853_bib142","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1007\/s12272-024-01499-w","article-title":"Exploring molecular mechanisms, therapeutic strategies, and clinical manifestations of Huntington's disease","volume":"47","author":"Shafie","year":"2024","journal-title":"Arch Pharm. Res. (Seoul)"},{"key":"10.1016\/j.ejphar.2025.177853_bib143","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1146\/annurev.biochem.75.103004.142422","article-title":"Chromatin modifications by methylation and ubiquitination: implications in the regulation of gene expression","volume":"75","author":"Shilatifard","year":"2006","journal-title":"Annu. Rev. Biochem."},{"key":"10.1016\/j.ejphar.2025.177853_bib144","doi-asserted-by":"crossref","first-page":"537","DOI":"10.3389\/fphar.2020.00537","article-title":"Histone deacetylases inhibitors in neurodegenerative diseases, neuroprotection and neuronal differentiation","volume":"11","author":"Shukla","year":"2020","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.ejphar.2025.177853_bib145","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s12038-019-9974-3","article-title":"Regulation of epigenetic state by non-histone chromatin proteins and transcription factors: implications in disease","volume":"45","author":"Sikder","year":"2020","journal-title":"J. Biosci."},{"key":"10.1016\/j.ejphar.2025.177853_bib146","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13148-021-01158-7","article-title":"Cellular reprogramming and epigenetic rejuvenation","volume":"13","author":"Simpson","year":"2021","journal-title":"Clin. Epigenet."},{"key":"10.1016\/j.ejphar.2025.177853_bib147","doi-asserted-by":"crossref","unstructured":"Singh, V., Mishra, V.N., Role of Epigenetics on Synaptic Plasticity in Neurodegenerative Disorders, Synaptic Plasticity in Neurodegenerative Disorders. CRC Press, pp. 72-92.","DOI":"10.1201\/9781003464648-6"},{"key":"10.1016\/j.ejphar.2025.177853_bib148","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pgen.1004574","article-title":"Dopamine signaling leads to loss of polycomb repression and aberrant gene activation in experimental parkinsonism","volume":"10","author":"S\u00f6dersten","year":"2014","journal-title":"PLoS Genet."},{"key":"10.1016\/j.ejphar.2025.177853_bib149","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1515\/revneuro-2021-0118","article-title":"The protective effects of activating Sirt1\/NF-\u03baB pathway for neurological disorders","volume":"33","author":"Song","year":"2022","journal-title":"Rev. Neurosci."},{"key":"10.1016\/j.ejphar.2025.177853_bib150","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1515\/revneuro-2023-0108","article-title":"Escape from X-chromosome inactivation and sex differences in Alzheimer's disease","volume":"35","author":"Song","year":"2024","journal-title":"Rev. Neurosci."},{"key":"10.1016\/j.ejphar.2025.177853_bib151","doi-asserted-by":"crossref","first-page":"2275","DOI":"10.3390\/biomedicines11082275","article-title":"Brain-derived neurotrophic factor dysregulation as an essential pathological feature in Huntington's disease: mechanisms and potential therapeutics","volume":"11","author":"Speidell","year":"2023","journal-title":"Biomedicines"},{"key":"10.1016\/j.ejphar.2025.177853_bib152","doi-asserted-by":"crossref","DOI":"10.1111\/adb.12905","article-title":"Nicotine abolishes memory\u2010related synaptic strengthening and promotes synaptic depression in the neurogenic dentate gyrus of miR\u2010132\/212 knockout mice","volume":"26","author":"Stojanovic","year":"2021","journal-title":"Addict. Biol."},{"key":"10.1016\/j.ejphar.2025.177853_bib153","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1002\/ijc.23607","article-title":"Modes of action of the DNA methyltransferase inhibitors azacytidine and decitabine","volume":"123","author":"Stresemann","year":"2008","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.ejphar.2025.177853_bib154","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1016\/j.nbd.2013.01.022","article-title":"G9a-mediated histone methylation regulates ethanol-induced neurodegeneration in the neonatal mouse brain","volume":"54","author":"Subbanna","year":"2013","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.ejphar.2025.177853_bib155","doi-asserted-by":"crossref","first-page":"6645","DOI":"10.3390\/ijms24076645","article-title":"Unraveling the complex interplay between alpha-synuclein and epigenetic modification","volume":"24","author":"Sugeno","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ejphar.2025.177853_bib156","doi-asserted-by":"crossref","DOI":"10.1038\/srep36328","article-title":"\u03b1-Synuclein enhances histone H3 lysine-9 dimethylation and H3K9me2-dependent transcriptional responses","volume":"6","author":"Sugeno","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ejphar.2025.177853_bib157","doi-asserted-by":"crossref","first-page":"150","DOI":"10.3390\/brainsci13010150","article-title":"\u03b1-Synuclein and mechanisms of epigenetic regulation","volume":"13","author":"Surguchov","year":"2023","journal-title":"Brain Sci."},{"key":"10.1016\/j.ejphar.2025.177853_bib158","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1016\/j.neuron.2013.10.023","article-title":"The emerging field of neuroepigenetics","volume":"80","author":"Sweatt","year":"2013","journal-title":"Neuron"},{"key":"10.1016\/j.ejphar.2025.177853_bib159","doi-asserted-by":"crossref","first-page":"7235","DOI":"10.3390\/ijms24087235","article-title":"Harnessing epigenetics for breast cancer therapy: the role of DNA methylation, histone modifications, and MicroRNA","volume":"24","author":"Szczepanek","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ejphar.2025.177853_bib160","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1038\/nrd4580","article-title":"Prospects for the development of epigenetic drugs for CNS conditions","volume":"14","author":"Szyf","year":"2015","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.ejphar.2025.177853_bib161","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1038\/nrm.2016.8","article-title":"A decade of transcription factor-mediated reprogramming to pluripotency","volume":"17","author":"Takahashi","year":"2016","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.ejphar.2025.177853_bib162","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1038\/nmeth.3733","article-title":"Editing the epigenome: technologies for programmable transcription and epigenetic modulation","volume":"13","author":"Thakore","year":"2016","journal-title":"Nat. Methods"},{"key":"10.1016\/j.ejphar.2025.177853_bib163","doi-asserted-by":"crossref","first-page":"5629","DOI":"10.18632\/oncotarget.13562","article-title":"Whole genome DNA methylation: beyond genes silencing","volume":"8","author":"Tirado-Magallanes","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.ejphar.2025.177853_bib164","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1212\/01.CON.0000455886.14298.a4","article-title":"ALS and other motor neuron diseases","volume":"20","author":"Tiryaki","year":"2014","journal-title":"CONTINUUM: Lifelong Learning in Neurology"},{"key":"10.1016\/j.ejphar.2025.177853_bib165","doi-asserted-by":"crossref","first-page":"1427","DOI":"10.3233\/JAD-215434","article-title":"Sporadic Alzheimer's disease-and neurotoxicity-related microRNAs affecting key events of tau-driven adverse outcome pathway toward memory loss","volume":"86","author":"Tsamou","year":"2022","journal-title":"J. Alzheim. Dis."},{"key":"10.1016\/j.ejphar.2025.177853_bib166","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12929-021-00755-1","article-title":"The regulatory roles of microRNAs toward pathogenesis and treatments in huntington's disease","volume":"28","author":"Tung","year":"2021","journal-title":"J. Biomed. Sci."},{"key":"10.1016\/j.ejphar.2025.177853_bib167","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1007\/s12035-014-8715-8","article-title":"Transcription, epigenetics and ameliorative strategies in Huntington's disease: a genome-wide perspective","volume":"51","author":"Valor","year":"2015","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.ejphar.2025.177853_bib168","doi-asserted-by":"crossref","first-page":"993","DOI":"10.3390\/ijms25020993","article-title":"Harnessing the stem cell niche in regenerative medicine: innovative avenue to combat neurodegenerative diseases","volume":"25","author":"Velikic","year":"2024","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ejphar.2025.177853_bib169","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1016\/j.arr.2013.05.003","article-title":"Epigenetic mechanisms in alzheimer's disease: implications for pathogenesis and therapy","volume":"12","author":"Wang","year":"2013","journal-title":"Ageing Res. Rev."},{"key":"10.1016\/j.ejphar.2025.177853_bib170","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1038\/s41392-022-01211-8","article-title":"Epigenetic regulation of aging: implications for interventions of aging and diseases","volume":"7","author":"Wang","year":"2022","journal-title":"Signal Transduct. Targeted Ther."},{"key":"10.1016\/j.ejphar.2025.177853_bib171","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.1007\/s40120-024-00642-5","article-title":"Neuroendoscopic parafascicular evacuation of spontaneous intracerebral hemorrhage (NESICH technique): a multicenter technical experience with preliminary findings","volume":"13","author":"Wang","year":"2024","journal-title":"Neurol. Therap."},{"key":"10.1016\/j.ejphar.2025.177853_bib172","doi-asserted-by":"crossref","DOI":"10.1016\/j.neulet.2021.136196","article-title":"Impacts of DNA methylation on tau protein related genes in the brains of patients with Alzheimer's disease","volume":"763","author":"Wei","year":"2021","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.ejphar.2025.177853_bib173","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0167201","article-title":"The role of DNA methylation and histone modifications in neurodegenerative diseases: a systematic review","volume":"11","author":"Wen","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.ejphar.2025.177853_bib174","doi-asserted-by":"crossref","first-page":"1514","DOI":"10.1902\/jop.2008.080172","article-title":"Epigenetic regulation of gene expression in the inflammatory response and relevance to common diseases","volume":"79","author":"Wilson","year":"2008","journal-title":"J. Periodontol."},{"key":"10.1016\/j.ejphar.2025.177853_bib175","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1093\/hmg\/ddaa022","article-title":"TET2-mediated Cdkn2A DNA hydroxymethylation in midbrain dopaminergic neuron injury of Parkinson's disease","volume":"29","author":"Wu","year":"2020","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.ejphar.2025.177853_bib176","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1111\/jnc.13646","article-title":"DNA methylation in parkinson's disease","volume":"139","author":"W\u00fcllner","year":"2016","journal-title":"J. Neurochem."},{"key":"10.1016\/j.ejphar.2025.177853_bib177","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1016\/j.ajhg.2013.04.017","article-title":"Hypermethylation of the CpG island near the G4C2 repeat in ALS with a C9orf72 expansion","volume":"92","author":"Xi","year":"2013","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.ejphar.2025.177853_bib178","doi-asserted-by":"crossref","first-page":"152","DOI":"10.3390\/biology12020152","article-title":"Dynamic regulation of DNA methylation and brain functions","volume":"12","author":"Xie","year":"2023","journal-title":"Biology"},{"key":"10.1016\/j.ejphar.2025.177853_bib179","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1007\/s13670-012-0027-0","article-title":"Epigenetics-based therapeutics for neurodegenerative disorders","volume":"1","author":"Xu","year":"2012","journal-title":"Curr. Geriatrics Rep."},{"key":"10.1016\/j.ejphar.2025.177853_bib180","doi-asserted-by":"crossref","DOI":"10.1016\/j.compbiomed.2023.107802","article-title":"Mapping enhancer and chromatin accessibility landscapes charts the regulatory network of alzheimer's disease","volume":"168","author":"Xu","year":"2024","journal-title":"Comput. Biol. Med."},{"key":"10.1016\/j.ejphar.2025.177853_bib181","doi-asserted-by":"crossref","DOI":"10.1038\/sj.onc.1210599","article-title":"HATs and HDACs: from structure, function and regulation to novel strategies for therapy and prevention","volume":"26","author":"Yang","year":"2007","journal-title":"Oncogene"},{"key":"10.1016\/j.ejphar.2025.177853_bib182","first-page":"1","article-title":"METTL3-dependent m6A modification of SNAP29 induces \u201cautophagy-mitochondrial crisis\u201d in the ischemic microenvironment after soft tissue transplantation","author":"Yang","year":"2025","journal-title":"Autophagy"},{"key":"10.1016\/j.ejphar.2025.177853_bib183","doi-asserted-by":"crossref","first-page":"145","DOI":"10.3233\/JPD-223517","article-title":"DNA methylation signature of aging: potential impact on the pathogenesis of parkinson's disease","volume":"13","author":"Yazar","year":"2023","journal-title":"J. Parkinsons Dis."},{"key":"10.1016\/j.ejphar.2025.177853_bib184","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1038\/s41583-020-0334-y","article-title":"In vivo locus-specific editing of the neuroepigenome","volume":"21","author":"Yim","year":"2020","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.ejphar.2025.177853_bib185","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbr.2021.113584","article-title":"Overexpression of miR-132-3p contributes to neuronal protection in in vitro and in vivo models of Alzheimer's disease","volume":"417","author":"Zeng","year":"2022","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.ejphar.2025.177853_bib186","doi-asserted-by":"crossref","DOI":"10.1016\/j.jbiomech.2024.112456","article-title":"Differences between two maximal principal strain rate calculation schemes in traumatic brain analysis with in-vivo and in-silico datasets","volume":"179","author":"Zhan","year":"2025","journal-title":"J. Biomech."},{"key":"10.1016\/j.ejphar.2025.177853_bib187","article-title":"Alzheimer's disease and microRNA-132: a widespread pathological factor and potential therapeutic target","volume":"15","author":"Zhang","year":"2021","journal-title":"Front. Neurosci."},{"key":"10.1016\/j.ejphar.2025.177853_bib188","doi-asserted-by":"crossref","first-page":"4893","DOI":"10.1007\/s12035-015-9415-8","article-title":"The role of MAPT in neurodegenerative diseases: genetics, mechanisms and therapy","volume":"53","author":"Zhang","year":"2016","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.ejphar.2025.177853_bib189","doi-asserted-by":"crossref","first-page":"2123","DOI":"10.3390\/cancers12082123","article-title":"DNA methyltransferases in cancer: biology, paradox, aberrations, and targeted therapy","volume":"12","author":"Zhang","year":"2020","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.ejphar.2025.177853_bib190","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1007\/s40120-021-00279-8","article-title":"Hematoma evacuation via image-guided para-corticospinal tract approach in patients with spontaneous intracerebral hemorrhage","volume":"10","author":"Zhang","year":"2021","journal-title":"Neurol. Therap."},{"key":"10.1016\/j.ejphar.2025.177853_bib191","article-title":"The role of non-coding RNAs in Alzheimer's disease: from regulated mechanism to therapeutic targets and diagnostic biomarkers","volume":"13","author":"Zhang","year":"2021","journal-title":"Front. Aging Neurosci."},{"key":"10.1016\/j.ejphar.2025.177853_bib192","doi-asserted-by":"crossref","first-page":"1748","DOI":"10.1002\/med.21962","article-title":"Targeting epigenetic modifications in parkinson's disease therapy","volume":"43","author":"Zhang","year":"2023","journal-title":"Med. Res. Rev."},{"key":"10.1016\/j.ejphar.2025.177853_bib193","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1038\/s41392-023-01537-x","article-title":"TET (Ten-eleven translocation) family proteins: structure, biological functions and applications","volume":"8","author":"Zhang","year":"2023","journal-title":"Signal Transduct. Targeted Ther."},{"key":"10.1016\/j.ejphar.2025.177853_bib194","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1007\/s12035-015-9658-4","article-title":"Brain REST\/NRSF is not only a silent repressor but also an active protector","volume":"54","author":"Zhao","year":"2017","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.ejphar.2025.177853_bib195","doi-asserted-by":"crossref","DOI":"10.1016\/j.arr.2024.102324","article-title":"Role of histone modifications in neurogenesis and neurodegenerative disease development","author":"Zhao","year":"2024","journal-title":"Ageing Res. Rev."},{"key":"10.1016\/j.ejphar.2025.177853_bib196","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1186\/s13677-024-00675-z","article-title":"Computational intelligence-based classification system for the diagnosis of memory impairment in psychoactive substance users","volume":"13","author":"Zhu","year":"2024","journal-title":"J. Cloud Comput."},{"key":"10.1016\/j.ejphar.2025.177853_bib197","article-title":"The association and prognostic implications of long non-coding RNAs in major psychiatric disorders, alzheimer's diseases and parkinson's diseases: a systematic review","volume":"25","author":"Zhu","year":"2024","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ejphar.2025.177853_bib198","doi-asserted-by":"crossref","first-page":"15","DOI":"10.3390\/epigenomes4030015","article-title":"Epigenomic remodeling in Huntington's Disease\u2014Master or servant?","volume":"4","author":"Zimmer-Bensch","year":"2020","journal-title":"Epigenomes"},{"key":"10.1016\/j.ejphar.2025.177853_bib199","doi-asserted-by":"crossref","DOI":"10.3390\/ijms222312736","article-title":"DNA methylation in huntington's disease","volume":"22","author":"Zsindely","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ejphar.2025.177853_bib200","doi-asserted-by":"crossref","first-page":"671","DOI":"10.3233\/JAD-180259","article-title":"Neuroepigenetics and Alzheimer's disease: an update","volume":"64","author":"Zusso","year":"2018","journal-title":"J. Alzheim. Dis."}],"container-title":["European Journal of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299925006077?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299925006077?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T20:28:00Z","timestamp":1778876880000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014299925006077"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9]]},"references-count":200,"alternative-id":["S0014299925006077"],"URL":"https:\/\/doi.org\/10.1016\/j.ejphar.2025.177853","relation":{},"ISSN":["0014-2999"],"issn-type":[{"value":"0014-2999","type":"print"}],"subject":[],"published":{"date-parts":[[2025,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Epigenetic reprogramming as a therapeutic strategy for neurodegenerative diseases: A complex and novel approach","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejphar.2025.177853","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"177853"}}